文献速递免疫规划传染病防控与疫情报告

北京儿童医院2013-2019年住院儿童肺炎链球菌血清型分布

Serotype distribution of Streptococcus pneumoniae isolated from children hospitalized in Beijing children's hospital (2013-2019).
PubMed 文献 · Vaccine · 2020-10-21

该研究收集2013-2019年北京儿童医院住院患儿分离的903株肺炎链球菌,用荚膜肿胀反应检测血清型。常见血清型为19F、19A、23F、14、6A和6B,PCV13总体覆盖率83.2%,侵袭性分离株覆盖率显著更高。

要点

  • 常见血清型为19F、19A、23F、14、6A和6B。
  • PCV13总体覆盖率83.2%,侵袭性分离株覆盖率更高。
  • PCV13或更高价疫苗预防儿童肺炎链球菌感染可能获益更大。

核心结论

  • 19F、19A、23F、14、6A和6B是2013-2019年北京儿童医院住院患儿肺炎链球菌分离株中最常见的血清型。
  • 现有肺炎链球菌疫苗中PCV13覆盖率较高,尤其在侵袭性感染分离株中。
  • 推广PCV13或更高价疫苗可能比其他肺炎链球菌疫苗在预防儿童肺炎链球菌感染方面获益更大。

研究设计与样本

  • 研究收集2013-2019年北京儿童医院住院儿童中鉴定为致病病原的肺炎链球菌分离株,共903株。
  • 采用荚膜肿胀反应(Quellung reaction)检测血清型。
  • 809株来自非侵袭性感染,94株来自侵袭性感染。

主要发现

  • 非侵袭性分离株主要来自呼吸道分泌物(49.4%)和支气管肺泡灌洗液(38.9%)。
  • 侵袭性分离株来自静脉血(5.4%)、脑脊液(2.8%)和胸腔积液(2.8%)。
  • 主要血清型为19F(36.0%)、19A(13.6%)、23F(9.4%)、14(8.9%)、6A(6.9%)和6B(5.3%)。

关键数值与推荐

  • PCV10、PCV13、PCV15、PCV20、PPV23和Pneumosil的总体覆盖率分别为61.6%、83.2%、83.4%、88.0%、82.4%和81.6%。
  • PCV13、PCV15和PPV23在侵袭性感染分离株中的覆盖率显著高于非侵袭性感染分离株。
  • Pneumosil总体覆盖率及不同年龄组、不同感染类型中的覆盖率均显著高于PCV10。

临床怎么用

  • 应关注PCV13在侵袭性肺炎链球菌感染中的较高覆盖率,考虑推广PCV13或更高价疫苗以预防儿童感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Streptococcus pneumoniae can cause many infectious diseases among children, and relevant vaccines have not been scheduled into the National Immunization Program in China. The serotype distribution of Streptococcus pneumoniae is essential information used to evaluate the value of pneumococcal vaccines and formulate immunization strategies. METHODS: Streptococcus pneumoniae isolates, identified as the disease pathogens, were collected from children hospitalized in Beijing Children's Hospital from 2013 to 2019. The serotype was detected by the Quellung reaction. RESULTS: A total of 903 isolates of Streptococcus pneumoniae were collected, among which 809 were from non-invasive infections and 94 were from invasive infections. The non-invasive isolates were mainly isolated from respiratory secretions (49.4%) and bronchoalveolar lavage fluid (38.9%), while invasive isolates were from venous blood (5.4%), cerebrospinal fluid (2.8%) and pleural effusion (2.8%). The leading serotypes were 19F (36.0%), 19A (13.6%), 23F (9.4%), 14 (8.9%), 6A (6.9%), and 6B (5.3%). The overall coverage rates of 10-, 13-, 15-, 20-valent pneumococcal conjugate vaccines (PCV10, PCV13, PCV15, PCV20) and 23-valent pneumococcal polysaccharide vaccine (PPV23) as well as Pneumosil (a 10-valent pneumococcal conjugate vaccine) were 61.6%, 83.2%, 83.4%, 88.0%, 82.4% and 81.6%, respectively. The coverage rates of PCV13, PCV15 and PPV23 in isolates from invasive infections were significantly higher than those from non-invasive infections. The coverage rates of Pneumosil, either on the whole or among different age groups or different infections, were significantly higher than those of PCV10. CONCLUSIONS: Serotypes 19F, 19A, 23F, 14, 6A and 6B were the most common types among the isolates. As for pneumococcal vaccines available now, the coverage rate of PCV13 was high, especially in isolates from invasive infections. The promotion of PCV13 or further high valent vaccines might be of greater benefit in preventing pneumococcal infections than other pneumococcal vaccines in children.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wang Q, Shi W, Li Y, et al. Serotype distribution of Streptococcus pneumoniae isolated from children hospitalized in Beijing children's hospital (2013-2019). Vaccine. 2020. PMID: 33164807. doi:10.1016/j.vaccine.2020.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。